Insider · CIK 0001986806
Arvind Kush
Files at IKT (Inhibikase Therapeutics, Inc.). First filing Oct 23, 2024, latest Oct 23, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IKT: Inhibikase Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Inhibikase Therapeutics, Inc. | $199k 145,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +108,176 | $0.00 | $0 | 108,176 | Jul 2, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +56,600 | $0.00 | $0 | 56,600 | Feb 19, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +116,585 | $0.00 | $0 | 116,585 | Feb 19, 2025 |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | POpen-market purchase Common Stock | +145,000 | $1.37 | $199k | 145,000 | Oct 23, 2024 |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.